Brandi Vollmer

Statistics

Publications

Citations

326

H-Index

Active since

2017

Affiliations

Rocky Mountain MS Center(Current)

University of Colorado Denver

University of Colorado Anschutz Medical Campus

Cleveland Clinic

Columbia University

Brandi Vollmer is an author at Rocky Mountain MS Center specializing in multiple sclerosis therapy, multiple sclerosis pharmacotherapy, and multiple sclerosis.

ORCID

Publications per year

2017–2022

Publications

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

Brandi Vollmer, Asya I. Wallach, John R. Corboy et al. · Annals of Clinical and Translational Neurology · 2020 · 97 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +13

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis

Brandi Vollmer, Andrew B. Wolf, Stefan Sillau et al. · Frontiers in Neurology · 2022 · 52 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Epidemiology +14

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience

Brandi Vollmer, Kavita Nair, Stefan Sillau et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2017 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers

Brandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay et al. · Neurology Clinical Practice · 2018 · 29 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment

Brandi Vollmer, Kavita Nair, Stefan Sillau et al. · Annals of Clinical and Translational Neurology · 2020 · 28 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

1–5 of 10